Prevalence of Reproductive Tract Infections, Abnormal Cervical Cytology, and High-Risk Human Papillomavirus among Heterosexual Women Living with HIV in Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260421003

Enrollment

264

Registered

2026-04-21

Start date

2026-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive tract infections including Chlamydia trachomatis and Neisseria gonorrhoeae, high-risk human papillomavirus infection, and cervical cytological abnormalities in women living with HIV HIV Infections, Chlamydia trachomatis, Chlamydia Infections, Neisseria gonorrhoeae, Gonorrhea, Human Papillomavirus, Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia, Sexually Transmitted Diseases, Women, Thailand, Prevalence, Retrospective Studies

Interventions

Women living with HIV aged 18 years or older who received care at Siriraj Hospital and underwent screening for sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae) and cervic

Screening

Women living with HIV

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female patients aged 18 years or older 2. Diagnosed with HIV infection (documented in medical records) 3. History of vaginal intercourse with male partners within the past 12 months 4. Asymptomatic at the time of screening 5. Had test results for Chlamydia trachomatis and Neisseria gonorrhoeae, cervical cytology (Pap smear), and high-risk HPV testing available in medical records

Exclusion criteria

Exclusion criteria: Incomplete medical records

Design outcomes

Primary

Measure	Time frame
Prevalence of Chlamydia trachomatis infection At the time of screening visit (retrospective data collection) Wet smear, PCR of Chlamydia trachomatis	—

Secondary

Measure	Time frame
Prevalence of Neisseria gonorrhoeae infection At the time of screening visit (retrospective data collection) Wet smear and PCR of Neisseria gonorrhoeae,Prevalence of cervical cytological abnormalities and high-risk HPV infection At the time of screening visit (retrospective data collection) Pap smear and high risk HPV-testing (Co-testing),Prevalence of colposcopic abnormalities At the time of colposcopy examination (retrospective data collection) Proportion of participants with abnormal colposcopic findings among those with indications for colposcopy (Standard Colposcope, Colposcope Karl Kaps SOM 52, Germany with 3.4-21.2 magnification),Associated factors for reproductive tract infections and cervical abnormalities At the time of screening visit (retrospective data collection) Demographic and clinical characteristics associated with outcomes	—

Measure

Time frame

Prevalence of Neisseria gonorrhoeae infection At the time of screening visit (retrospective data collection) Wet smear and PCR of Neisseria gonorrhoeae,Prevalence of cervical cytological abnormalities and high-risk HPV infection At the time of screening visit (retrospective data collection) Pap smear and high risk HPV-testing (Co-testing),Prevalence of colposcopic abnormalities At the time of colposcopy examination (retrospective data collection) Proportion of participants with abnormal colposcopic findings among those with indications for colposcopy (Standard Colposcope, Colposcope Karl Kaps SOM 52, Germany with 3.4-21.2 magnification),Associated factors for reproductive tract infections and cervical abnormalities At the time of screening visit (retrospective data collection) Demographic and clinical characteristics associated with outcomes

—

Countries

Thailand

Contacts

Public ContactNapat Srimusikapo

Thammasat University Hospital

napat.obgyn@gmail.com0959954522

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026